We use cookies on our website. Some are necessary for the operation of the website. You can also allow cookies for statistical purposes. You can adjust the data protection settings or agree to all cookies directly.
Data Protection Declaration
Imprint
Boehringer Ingelheim Pharma GmbH & Co. KG
Institution
Section overview
Description
Boehringer Ingelheim is an independent, explorative and manufacturing pharmaceutical companies - and this will remain so. The growth is taking place on its own merits. But also targeted acquisitions and synergies created with cooperation will contribute to the continuous success.
Activities
- Funding
- Research Support
Subordinate institutions
Coordinated projects of subordinate institutions
Financed funding programmes
Involved in research projects
- Development and improvment of calibration models for quantification of scopolamine in plant material of Duboisia cultivars by ATR-FTIR and application of different chemometric techniques
- Improvement of an in vitro stem cell assay for developmental toxicity: Establishing molecular endpoints of tissue specific development
- Lignocellulose Biorefinery
- Vibrational spectroscopic determination of alcaloids in variuos Solanaceae species
Contact
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Straße 173
55216 Ingelheim am Rhein
Rhineland-Palatinate
Germany
Phone: +49 06132 / 77-0
Fax: +49 06132 / 72-0
Email: presse(@)boehringer-ingelheim.de
